DPP4 and lung adenocarcinoma: So far, existing data about the expression and impact of CD26 in solid tumors are inconsistently reported; however, our data—and we consider this as a strength of this study—add more evidence to current literature on the role of CD26 and patient outcome in cancer in general and, for the first time, in lung adenocarcinoma in particular.